Paper40600656
Employing machine learning for identifying antifungal compounds against Candida albicans.
de Souza DR and 6 others. Future Microbiol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Employing machine learning for identifying antifungal compounds against Candida albicans. Papers, record 40600656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40600656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Employing machine learning for identifying antifungal compounds against Candida albicans.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Candida albicans | Major topic |
| Antifungal Agents | Major topic |
| Machine Learning | Major topic |
| Microbial Sensitivity Tests | |
| Algorithms | |
| Drug Evaluation, Preclinical | |
| Humans |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23487382 | Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23487382 | PubMed |
| 2 | 30364128 | Comparison of Quantitative and Qualitative (Q)SAR Models Created for the Prediction of Ki and IC50 Values of Antitarget Inhibitors. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30364128 | PubMed |
| 3 | 30524275 | QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30524275 | PubMed |
| 4 | 21948594 | ChEMBL: a large-scale bioactivity database for drug discovery. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/21948594 | PubMed |
| 5 | 25558886 | DataWarrior: an open-source program for chemistry aware data visualization and analysis. | J Chem Inf Model | 2015 | https://conductscience.org/library/papers/25558886 | PubMed |
| 6 | 22625864 | Colloidal aggregation affects the efficacy of anticancer drugs in cell culture. | ACS Chem Biol | 2012 | https://conductscience.org/library/papers/22625864 | PubMed |
| 7 | 29325167 | A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/29325167 | PubMed |
| 8 | 19319021 | Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs. | Pediatr Infect Dis J | 2009 | https://conductscience.org/library/papers/19319021 | PubMed |
| 9 | 14632445 | Random forest: a classification and regression tool for compound classification and QSAR modeling. | J Chem Inf Comput Sci | 2003 | https://conductscience.org/library/papers/14632445 | PubMed |
| 10 | 20572635 | Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. | J Chem Inf Model | 2010 | https://conductscience.org/library/papers/20572635 | PubMed |
| 11 | 30895218 | Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/30895218 | PubMed |
| 12 | 26295373 | An Aggregation Advisor for Ligand Discovery. | J Med Chem | 2015 | https://conductscience.org/library/papers/26295373 | PubMed |
| 13 | 31228646 | Candida auris and multidrug resistance: Defining the new normal. | Fungal Genet Biol | 2019 | https://conductscience.org/library/papers/31228646 | PubMed |
| 14 | 18550376 | QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds. | Bioorg Med Chem | 2008 | https://conductscience.org/library/papers/18550376 | PubMed |
| 15 | 12036371 | Molecular properties that influence the oral bioavailability of drug candidates. | J Med Chem | 2002 | https://conductscience.org/library/papers/12036371 | PubMed |
| 16 | 33228010 | Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going? | J Fungi (Basel) | 2020 | https://conductscience.org/library/papers/33228010 | PubMed |
| 17 | 27988485 | Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. | Clin Infect Dis | 2017 | https://conductscience.org/library/papers/27988485 | PubMed |
| 18 | 31161036 | Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. | Antimicrob Resist Infect Control | 2019 | https://conductscience.org/library/papers/31161036 | PubMed |
| 19 | 32069285 | Deep Learning-driven research for drug discovery: Tackling Malaria. | PLoS Comput Biol | 2020 | https://conductscience.org/library/papers/32069285 | PubMed |
| 20 | 28744860 | Echinocandins in antifungal pharmacotherapy. | J Pharm Pharmacol | 2017 | https://conductscience.org/library/papers/28744860 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42783954 | A Review of the Therapeutic Challenges and Novel Treatment Options in Mitigating Invasive Mycosis Associated with Aspergillus, Candida, Cryptococcus, and Pneumocystis. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42783954 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40600656
GET https://conductscience.org/api/papers/v1/40600656/references?page=2